Article | Open | Published:

Derivation of induced pluripotent stem cells in Japanese macaque (Macaca fuscata)


Non-human primates are our closest relatives and are of special interest for ecological, evolutionary and biomedical research. The Japanese macaque (Macaca fuscata) has contributed to the progress of primatology and neurosciences over 60 years. Despite this importance, the molecular and cellular basis of the Japanese macaque remains unexplored since useful cellular tools are lacking. Here we generated induced pluripotent stem cells (iPSCs) from skin fibroblasts of the Japanese macaque with Sendai virus or plasmid vectors. The Japanese macaque iPSCs (jm-iPSCs) were established under feeder-free culture conditions, but feeder cells turned out to be essential for their maintenance. The jm-iPSCs formed human iPSC-like flat colonies which were positive for pluripotent antigens including alkaline phosphatase, SSEA4, and TRA-1-81. They also expressed endogenous OCT3/4, SOX2, L-MYC, and KLF4 and other pluripotent marker genes. The potential to differentiate into all three germ layers and neural stem cells was confirmed by embryoid body and neurosphere formation, respectively. The jm-iPSCs will provide a robust in vitro tool for investigating the underlying mechanisms of development and physiology studies with the Japanese macaque.


The Japanese macaque (Macaca fuscata) is one species of the Asian macaque monkeys along with rhesus and cynomolgus monkeys. The Japanese macaque - also known as the snow monkey - is native to Japan and is the most northern living non-human primate species. Historically, field researchers have studied social behavior and ecology of the Japanese macaque for more than half a century for religious reasons, leading to the pioneering of primatology in Japan1,2,3. The Japanese macaque also has attracted researcher’s attention in laboratories as a valuable experimental animal model due to their anatomical and physiological similarities to humans, their high cognitive ability, and their gentle and patient character4. Especially, the Japanese macaque has contributed to the advance of neuroscience5 through the investigations of brain activity and cognition6,7,8,9, neural pathway and gene expression10,11, and spontaneous mutant monkeys12,13,14,15. From the above, the Japanese macaque has been employed as an excellent primate model with the accumulated knowledge and a potential to integrate the laboratory studies with the field research. However, difficulties in developmental physiology and genetic manipulations in vivo restrict in-depth analyses of molecular and cellular mechanisms in the Japanese macaque biology.

Induced pluripotent stem cells (iPSCs) can provide a new strategy to compensate this experimental concern of the Japanese macaque. iPSCs are a new type of pluripotent stem cells that have revolutionized stem cell biology and medicine16,17 and have a huge potential for evolutionary and comparative genomic approaches18,19,20,21,22,23,24,25,26. As pluripotent stem cells, iPSCs have a potential to differentiate into all three germ layers (ectoderm, mesoderm, and endoderm) and germ cells both in vivo and in vitro. Technically, iPSCs are regarded to have four experimental advantages in research. First, iPSCs can be generated from many different types of small biopsies of mammalian species with relatively simple protocols26,27,28. Second, iPSCs have robust and infinite proliferation activity while self-renewing. Third, iPSCs can reconstruct developmental events of interest in vitro, providing alternatives for invasive study using animal individuals. Fourth, iPSCs are amenable to genetic manipulations including genome editing. Thus, iPSCs can serve as a potent in vitro tool to address the molecular and cellular basis of development and physiology in the Japanese macaque.

In this study, we generated the Japanese macaque iPSCs (jm-iPSCs) from skin fibroblasts by transducing a set of human reprogramming factors with Sendai virus (SeV)27 or plasmid28,29 vectors. The jm-iPSCs were similar with human iPSCs in colony morphology, marker gene expression, and differentiation potency albeit their growth totally depended on feeder cells. Embryoid body and neurosphere formation cultures induced differentiation of the jm-iPSCs spontaneously into three germ layers or specifically into neural stem cells respectively. The jm-iPSCs will be a powerful in vitro counterpart to facilitate the Japanese macaque biology.

Materials and Methods


All experiments using primate samples in this study were approved by the Animal Care and Use Committee of Kyoto University Primate Research Institute (KUPRI) and were performed in accordance with the Guidelines for Care and Use of Nonhuman Primates (Version 3, 2010) published by KUPRI.

Generation of jm-iPSCs by Sendai virus vector infection and plasmid vector transduction

Japanese macaque skin fibroblasts (jm1481, 21-year-old female; jm2623, 6-day-old female) were cultured in the 15%FBS/DMEM medium consisting of Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 15% fetal bovine serum (FBS), 0.1 mM non-essential amino acids, 2 mM L-glutamine, 1 mM sodium pyruvate, 0.11 mM 2-mercaptoethanol, and 100 U/ml penicillin and 100 µg/ml streptomycin at 37 °C with 5% CO2.

SeV infection was performed using CytoTune-iPS 2.0 L (MBL, DV-0305) with a modified protocol. Briefly, 1 × 105 jm-fibroblasts were incubated in 100 μl of SeV mixture containing KOS(PM)-SeV/TS12ΔF, KLF4-SeV/TSΔF, and L-MYC(HNL)-SeV/TS15ΔF at a multiplicity of infection 5, 5, and 10 each at 37 °C for 1 hour. To assess the successful transduction, CytoTune-EmGFP SeV was also infected. The infected 5 × 104 cells were plated to the iMatrix 511-coated 6-well plates (day 0). The SeV-containing medium was exchanged to fresh 15%FBS/DMEM on day 1. For plasmid transfection, 1 × 105 jm-fibroblasts were transfected with pCXLE-hOct3/4-shp53-F, pCXLE-hSK, pCXLE-hUL28 and pCXWB-EBNA129 by Lipofectamine 3000 (Thermo Fisher Scientific, L3000). pCXLE-EGFP was used as a transfection control. After 6 days of culture with 15%FBS/DMEM, 5 × 104 cells were replated to the iMatrix 511 (Matrixome, 389-07364)-coated 35-mm plates.

In both cultures, the medium was exchanged to mTeSR1 (StemCell Technologies, ST0580) on day 7 and medium change was performed every other day. The resulting iPSC-like colonies were mechanically isolated and incubated with TrypLE Select (Life Technologies, 12563029). The cells were plated to iMatrix 511-coated plates and cultured with StemFit (Ajinomoto, AK02N) supplemented with 10 μM of Y-27632 (Wako, 253-00513). After several passages, the jm-iPSCs were maintained on mitomycin-treated SNL feeder cells with StemFit at 37 °C with 5% CO2

Chromosome analysis

The jm-iPSCs at a 70~80% confluency were treated with 50 ng/ml colcemid for 40 minutes. The cells were harvested by TrypLE Express, treated with 0.56% KCl for 20 minutes at room temperature, and fixed with ethanol-acetic acid (3:1) for 10 minutes on ice30. Chromosome spreads were prepared with one drop of fixed cell suspension. After treatment with 0.05% IGEPAL CA-630, the chromosome samples were stained with ProLong Diamond Antifade Mountant with DAPI (Thermo Fisher Scientific, P36966). Karyotyping of chromosomes was performed according to the previous report31.

Alkaline phosphatase, rBC2LCN lectin, and immunofluorescence analyses

Alkaline phosphatase staining and rBC2LCN live cell staining was performed using Leukocyte Alkaline Phosphatase kit (Sigma, 86R-1KT) and rBC2LCN-FITC (Wako, 180-02991) respectively, according to the manufacture’s instructions. For immunofluorescence microscopy, cells were fixed with 4% paraformaldehyde, permeabilized with 0.5% Triton-X, blocked with 5% skim milk, and incubated with primary antibodies. The following primary antibodies were used: mouse anti-OCT4 (BD Biosciences, 611202), rabbit anti-NANOG (REPROCELL, RCAB0003P), goat anti-LIN28A (R&D systems, AF3757), rabbit anti-DPPA4 (Abcam, ab154642), mouse anti-SOX2 (R&D systems, MAB2018), rabbit anti-SALL4 (Abcam, ab29112), mouse anti-SSEA4 (Millipore, MAB4304), mouse anti-TRA-1-81 (Millipore, MAB4381), mouse anti-E-CADHERIN (BD Biosciences, 610182), mouse anti-Keratan sulfate (R-10G) (Wako, 011-25811), mouse anti-TUBULIN β3 (BioLegend, MMS-435P), mouse anti-α-SMA (Abcam, ab7817), rabbit anti-VIMENTIN (Abcam, ab92547), goat anti-SOX17 (R&D systems, AF1924), mouse anti-AFP (R&D systems, MAB1369), mouse anti-NESTIN (Millipore, MAB5326), rabbit anti-PAX6 (Wako, 019-27291), rabbit anti-MAP2 (Millipore, AB5622), mouse anti-DREBRIN (Wako, 015-27271) antibodies. Secondary antibodies included Alexa Fluor Plus 488 goat anti-mouse IgG (Thermo Fisher Scientific, A32723), Alexa Fluor 488 donkey anti-goat IgG (Thermo Fisher Scientific, A11055), Alexa Fluor 555 donkey anti-mouse IgG (Abcam, ab150110), Alexa Fluor 555 donkey anti-rabbit IgG (Thermo Fisher Scientific, A31572). Nuclei were stained with 1 µg/ml DAPI.

RT-PCR and PCR analyses

Total RNA was extracted using RNeasy Plus Mini Kit (Qiagen, 74104) and reverse transcribed using the PrimeScript RT reagent Kit with gDNA Eraser (TaKaRa, RR047A). Genomic DNA was isolated using DNeasy Blood & Tissue Kit (Qiagen, 69506). RT-PCR and PCR analyses were performed with Ex Taq Hot Start Version (TaKaRa, RR006A). All experiments were performed semiquantitatively at three different escalation cycles, and only representative images are shown in the result.

In vitro differentiation culture

For embryoid body (EB) formation, jm-iPSCs were dissociated and transferred to 6-well low attachment culture plates (corning) at 1 × 106 cells/ml in 15%FBS/DMEM. After 2 weeks culture, the EBs were transferred to Geltrex-coated plates and cultured at an adhesion condition with 15%FBS/DMEM for another 3 weeks.

For directed differentiation into neural stem cells, jm-iPSCs were transferred to 6-well low attachment plates in KBM Neural Stem Cell medium (Kohjin Bio, 16050200) supplemented with 2 μM dorsomorphin (Cayman, 11967), 10 μM SB431542 (Cayman, 13031), and 1 × B-27 (Gibco, 17504-044) at 1.5 × 105 cells/ml. Soon after iPSC dissociation, 10 μM Y-27632 was added to the medium. On day 1 and 4, 3 ng/ml Stembeads FGF2 (StemCultures, SB500) were added into the medium and the medium was half-exchanged on day 4. To induce neuronal differentiation, 1-week old neurospheres were plated onto Geltrex-coated culture plates and cultured in KBM Neural Stem Cell medium without FGF2 and EGF but supplemented with 1 × B-27 for 2 weeks.


To generate jm-iPSCs from primary skin fibroblasts (jm1481, jm2623), we applied two methods to transduce the reprogramming factors with SeV27 and plasmid28,29 vectors (Fig. 1a). Human POU5F1 (also known as OCT3/4), SOX2, KLF4, and L-MYC were transduced into jm-fibroblasts by SeV infection, while plasmid vectors bearing human OCT3/4, SOX2, KLF4, LIN28, L-MYC, and shRNA for TP53 were transfected with an additional EBNA1 plasmid by lipofection. In both cultures, the expression of GFP transgenes showed successful gene transduction into jm-fibroblasts albeit the transduction efficiency was much lower in the plasmid transfection (Fig. 1b). iPSC-like colonies appeared from jm2623 fibroblasts within 15 days after SeV infection and 25 days after plasmid transfection. Since jm1481 fibroblasts had a tendency to detach within 3 weeks after vector transduction, we re-plated the cells to a new plate on day 19. Human iPSC-like flat and clear-edged colonies were mechanically dissected and plated onto new dish on day 25 (jm2623 fibroblasts) or day 32 (jm1481 fibroblasts) (Fig. 1c).

Figure 1

Generation of jm-iPSCs from skin fibroblasts (a). Schematic design of jm-iPSC generation. SeV, Sendai virus system. Pla, plasmid vector system. (b) The expression of GFP transgenes in jm-fibroblasts (jm2623) on day 3 after SeV (upper) and plasmid vector (lower) transduction. Scale bar; 100 µm. (c) Phase contrast images of iPSC-like colony morphologies emerged from jm2623 (day 25, upper; SeV, lower; plasmid) and jm1481 fibroblasts (day 32, SeV). Scale bar; 100 µm. (d) Phase contrast images of jm-iPSCs (J5F1, derived from SeV-jm1481) grown on feeder cells or under feeder-free culture after staining for alkaline phosphatase. Scale bar; 500 µm. (e) RT-PCR analysis of SeV vectors. Jm-fibroblasts (jm1481) infected with SeV vectors carrying GFP or reprogramming factors (KOSL, day 3) were used as positive controls of SeV vectors. β-ACTIN was examined as an internal control. Full-length gels are presented in Supplementary Figure S1. (f) Genomic PCR analysis of plasmid transgenes. Each plasmid vector carrying reprogramming factors and water were used as a positive and negative control, respectively. An hCONDEL region was examined as an internal control. Full-length gels are presented in Supplementary Figure S1.

Although the jm-iPSC colonies emerged under feeder-free culture, feeder cells were required to maintain the jm-iPSCs in an undifferentiated state. The jm-iPSCs grown on feeder cells formed flat and tightly packed colonies with sharp edges, while cells under feeder-free culture gradually exhibited loose colonies showing a heterogenous alkaline phosphatase staining after serial passages (Fig. 1d). Mouse SNL cells or autologous jm-fibroblasts were effective as feeder cells therefore we utilized SNL cells because of its technical convenience. The jm-iPSCs could be expanded for more than 50 passages.

For characterization of the jm-iPSCs established, we used two different jm-iPSC lines J5F1 (derived from SeV-jm1481) and J9F2 (derived from plasmid-jm2623). SeV vectors replicate their RNA genomes in the cytoplasm of infected cells. During reprogramming, SeV vectors are gradually diluted but can sometimes be detected even in established iPSCs27. In J5F1 jm-iPSCs, no residual SeV vectors were detected by RT-PCR (Fig. 1e). We also performed PCR to detect plasmid transgenes in the established iPSC lines and identified a genomic integration of OCT3/4, L-MYC, LIN28, and EBNA1 in J9F2 jm-iPSCs (Fig. 1f).

The jm-iPSCs had normal karyotype (42 XX) (Fig. 2a, Supplementary Figure S3a). The jm-iPSCs were strongly positive for rBC2LCN lectin32 staining (Fig. 2b, Supplementary Figure S3b). Immunofluorescence analyses showed that the jm-iPSCs expressed other pluripotency intracellular antigens (OCT3/4, NANOG, LIN28, DPPA4, SOX2, SALL4) (Fig. 2c, Supplementary Figure S3c) and cell surface antigens (SSEA4, TRA-1-81, E-CADHERIN) (Fig. 2d, Supplementary Figure S3d). R-10G sugar chain epitope33 was also detected in the jm-iPSCs, indicating that the jm-iPSCs were highly reprogrammed pluripotent stem cells. RT-PCR revealed the expression of a set of pluripotency-associated genes, such as REX1, GDF3, and TERT, in the jm-iPSCs but not in the parental fibroblasts (Fig. 2e). The endogenous expression of OCT3/4, SOX2, L-MYC, and KLF4 was also induced in the jm-iPSCs. The expression of XIST showed that X chromosome reactivation did not occur in these female jm-iPSCs, suggesting their primed pluripotency.

Figure 2

Molecular characterization of jm-iPSCs (J5F1) (a). Chromosomal analysis of jm-iPSCs (J5F1). Scale bar; 10 µm. (b) Live staining of jm-iPSCs (J5F1) with rBC2LCN lectin. Scale bar; 200 µm. (c) Immunofluorescence analyses of pluripotency-associated proteins OCT4, NANOG, LIN28, DPPA4, SOX2, and SALL4. (d) Immunofluorescence analyses of pluripotency-associated cell surface antigens SSEA4, TRA-1-81, E-CADHERIN, and R-10G. Nuclei were counterstained with DAPI. Scale bar; 250 µm. (e) RT-PCR analyses of pluripotency-associated genes. β-ACTIN was examined as an internal control, and water was used as a negative control. Full-length gels are presented in Supplementary Figure S1.

Differentiation potency of jm-iPSCs was examined by embryoid body (EB) and neurosphere formation cultures. In EB formation culture, jm-iPSCs formed ball-like structures at a floating condition (Fig. 3a,b, Supplementary Figure S4a). When transferred to the adherent culture, the EBs expanded and various kinds of differentiated cells appeared spontaneously (Fig. 3c, Supplementary Figure S4b). Immunofluorescence analysis revealed differentiation to the ectoderm (TUJ1), mesoderm (α-SMA, VIMENTIN), and endoderm (SOX17, AFP) lineage in the EB outgrowth (Fig. 3d, Supplementary Figure S4c). The expression of the three germ layer markers in the EBs was also detected by RT-PCR analysis (Fig. 3e, Supplementary Figure S4d). However, compared to J5F1 jm-iPSCs, J9F2 jm-iPSCs were likely to have less differentiation potency. Then, neurosphere formation culture34,35,36 demonstrated the ability to directed differentiation into neural stem cells (Fig. 4a). The jm-iPSCs formed neurospheres in the presence of chemical dual SMAD inhibitors37 during 1-week floating culture (Fig. 4b, Supplementary Figure S5a). The neurospheres were then cultured at a neuronal differentiation condition for another 2 weeks (Fig. 4c, Supplementary Figure S5b). Immunofluorescence analysis detected the efficient production of neural stem cells (NESTIN+, PAX6+) and neurons (TUJ1+, MAP2+, DREBRIN+) in the differentiated neurospheres (Fig. 4d, Supplementary Figure S5c). Again, RT-PCR analysis also revealed the expression of neural stem/progenitor cells (GLAST, ASCL1 etc.) and neuron markers (DCX, VGLUT2 etc.) after neuronal differentiation of the neurospheres (Fig. 4e, Supplementary Figure S5d).

Figure 3

Differentiation potency of jm-iPSCs (J5F1) into three germ layers (a). Schematic design of embryoid body (EB)-mediated differentiation of jm-iPSCs. (b) jm-iPSC (J5F1)-derived EBs after 2-week floating culture. Scale bar; 200 µm. (c) Outgrowth of jm-iPSC (J5F1)-derived EBs at 3-week adherent culture. Representative images of differentiated cells are shown. Scale bar; 200 µm. (d) Immunofluorescence analyses of ectoderm (TUJ1), mesoderm (α-SMA, VIMENTIN), endoderm markers (SOX17, AFP) in the EB outgrowth. Nuclei were counterstained with DAPI. Scale bar; 100 µm. (e) RT-PCR analysis of differentiation marker genes in the floating EBs. β-ACTIN was examined as an internal control, and water was used as a negative control. Full-length gels are presented in Supplementary Figure S2.

Figure 4

Directed differentiation of jm-iPSCs (J5F1) into neural cells (a). Schematic design of neural differentiation of jm-iPSCs. (b) Neurospheres of jm-iPSCs (J5F1) after 1-week floating culture. Scale bar; 100 µm. (c) Neuronal differentiation of neurospheres after 2-week adherent culture. Scale bar; 200 µm. (d) Immunofluorescence analyses of neural stem cell (NESTIN, PAX6) and neuron markers (TUJ1, MAP2, DREBRIN) in 2-week neuronal differentiation culture of neurospheres. Nuclei were counterstained with DAPI. Scale bar; 100 µm. (e) RT-PCR analysis of neural marker genes. β-ACTIN was examined as an internal control, and water was used as a negative control. NS, neurospheres after 2-week neuronal differentiation culture. Full-length gels are presented in Supplementary Figure S2.


Here, we generated jm-iPSCs from adult and neonate skin fibroblasts by transducing human reprogramming factors with Sendai virus and plasmid vectors. Once established, the jm-iPSCs formed tight and flat colonies similarly to human iPSCs and grew over 50 passages. They expressed the pluripotency-associated genes and exhibited differentiation potency into all three germ layers. Basic molecular and cellular properties of the jm-iPSCs seemed to be similar with those of human iPSCs. To date, numerous number of methods have been developed to induce directed differentiation from human iPSCs into cell types of interest in vitro, and, among them, neurosphere formation culture36,37 could be applied to the jm-iPSCs to derive neural stem cells (Fig. 4, Supplementary Figure S5). Thus, in vitro differentiation protocols for human iPSCs are expected to be applicable to the jm-iPSCs. Experimental platforms have been set up to study in vitro developmental biology of the Japanese macaque and comparative Evo-Devo studies among primate species including human.

Although jm-iPSCs could be cultured basically referring to human iPSC protocols, Japanese macaque fibroblasts were not highly competent for lipofection-based gene transduction (Fig. 1b). In addition, feeder cells were necessary for long term maintenance of the jm iPSCs. For feeder-free culture of the jm-iPSCs, we used laminin-511 E8 coating in combination with StemFit medium that enables efficient feeder-free expansion of human iPSCs even after single cell dissociation38. We further assessed additional molecules (ID-839, GF109203X40, increased concentration of FGF2 etc.) or other coating reagents (Geltrex etc.), but none of them improved the feeder-free culture of jm-iPSCs (data not shown). Therefore, current feeder-free cultures that have devised for human iPSCs are not sufficient to maintain jm-iPSCs. It remains unclear whether this is due to species-specific cell culture requirements or cellular properties including reprogramming quality. To achieve a conventional feeder-free culture of jm-iPSCs, further investigations of culture conditions, including optimization for macaque monkeys rather than human, will be needed.

Mouse and human iPSC studies have revealed that reprogramming efficiency declines in a donor age-dependent manner41. Indeed, albeit jm-iPSCs could be generated from 6-day-old neonate (jm2623) and 21-year-old adult (jm1481) donor monkeys, the neonate showed a much higher amount of iPSC colonies upon reprogramming than the adult macaque (data not shown). It is also suggested that age-related genetic and epigenetic signatures inherited from donor cells may influence the quality of iPSCs42. When we compared the jm-iPSC lines J5F1 and J9F2, the differentiation potency seemed to be higher in adult-derived J5F1 than neonate-derived J9F2 iPSCs (Fig. 3, Supplementary Figure S4). Considering the low transduction efficiency and the genomic integration of transgenes in the plasmid transfection-derived iPSCs (Fig. 1b,f), the differences are likely to be explained by the transduction method and subsequent reprogramming quality rather than the donors age. To assess the effects of donor age and gene transduction methods on reprogramming in the Japanese macaque, it is necessary to characterize several jm-iPSC lines derived from various donors with different ages and reprogramming methods.

To date, several spontaneous mutant monkeys have been found in the Japanese macaque populations. For example, a child monkey in our institute was characterized by significant premature aging that exhibited common symptoms with human progeria, including deep skin wrinkles, cataract, poikiloderma, and shrinkage of cerebral cortex12. To identify the genes associated with these phenotypes, genomic DNA sequencing of this monkey was performed. However, no mutations in known genes that are responsible for the major human progeroid syndromes were detected so that the molecular basis underlying the premature aging remained unclear. In another case, a monkey that exhibited an autism spectrum disorder was reported14. This monkey exhibited impaired social ability, repetitive behaviors, and less neurons responsive to other monkey’s action. Genomic analyses of copy number variation and exome sequencing identified many mutations unique to this monkey including two genes associated with neuropsychiatric disorders in humans; however it remains to be determined whether these genes are actually causal for the phenotype. To fill the gap between phenotype and genotype, the jm-iPSCs from mutant monkeys are useful for in-depth, comprehensive analyses as demonstrated by disease-specific iPSCs in human43. Directed differentiation of mutant monkey jm-iPSCs enables researchers to model the pathophysiology and investigate its underlying mechanisms in vitro. Furthermore, functional assays of genetically manipulated candidate genes will give insight to their contribution to molecular circuits and cellular properties. This approach can be applied to wild type monkeys and a wide range of different primates as well, and intensively support neurosciences from the point of view of molecular, cellular, and developmental biology.

A recent study reported that approximately 60% of non-human primate species is under the risk of extinction and approximately 75% of the populations are decreasing in size44. To address this issue, multilateral efforts and solutions including preservation of their habitats or artificial breeding are needed. Given the technical advantages of iPSCs which are easy to generate and proliferate infinitely, the iPSC technology will serve as a backup system to preserve divergent bio-resources. For example, the establishment of a primate iPSC bank as a ‘frozen zoo’ is useful for keeping invaluable genetic materials in a viable condition45. Furthermore, considering recent progresses of germ cell production from iPSCs46, iPSCs-derived germ cells are likely to be a more direct means for future assisted reproduction. Primate iPSCs would provide a new strategy for conservation and reproduction of primate species, and the Japanese macaque and jm-iPSCs could be a good model for this challenge. This is also helpful to preserve bio-resources of the rare spontaneous mutant monkeys that are found incidentally in populations.

In conclusion, we generated iPSCs from the Japanese macaque fibroblasts with a reprogramming strategy optimized for human iPSCs. This new in vitro system would contribute to further development of primatology and neurosciences by facilitating the molecular and cellular understanding of Japanese macaque.

Additional information

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.

    Schofield, D. P., McGrew, W. C., Takahashi, A. & Hirata, S. Cumulative culture in nonhumans: overlooked findings from Japanese monkeys? Primates 59, 113–122, (2018).

  2. 2.

    Takahata, Y., Huffman, M. A., Suzuki, S., Koyama, N. & Yamagiwa, J. Why dominants do not consistently attain high mating and reproductive success: A review of longitudinal Japanese macaque studies. Primates 40, 143–158, (1999).

  3. 3.

    Leca, J. B. et al. A multidisciplinary view on cultural primatology: behavioral innovations and traditions in Japanese macaques. Primates 57, 333–338, (2016).

  4. 4.

    Isa, T., Yamane, I., Hamai, M. & Inagaki, H. Japanese macaques as laboratory animals. Exp Anim 58, 451–457, (2009).

  5. 5.

    Iriki, A. & Sakura, O. The neuroscience of primate intellectual evolution: natural selection and passive and intentional niche construction. Philos Trans R Soc Lond B Biol Sci 363, 2229–2241, (2008).

  6. 6.

    Miyamoto, K., Setsuie, R., Osada, T. & Miyashita, Y. Reversible Silencing of the Frontopolar Cortex Selectively Impairs Metacognitive Judgment on Non-experience in Primates. Neuron 97, 980–989 e986, (2018).

  7. 7.

    Yoshida, K., Saito, N., Iriki, A. & Isoda, M. Social error monitoring in macaque frontal cortex. Nat Neurosci 15, 1307–1312, (2012).

  8. 8.

    Samejima, K., Ueda, Y., Doya, K. & Kimura, M. Representation of action-specific reward values in the striatum. Science 310, 1337–1340, (2005).

  9. 9.

    Nakahara, K., Hayashi, T., Konishi, S. & Miyashita, Y. Functional MRI of macaque monkeys performing a cognitive set-shifting task. Science 295, 1532–1536, (2002).

  10. 10.

    Matsunaga, E. et al. Identification of tool use acquisition-associated genes in the primate neocortex. Dev Growth Differ 57, 484–495, (2015).

  11. 11.

    Ito, T., Inoue, K. & Takada, M. Distribution of glutamatergic, GABAergic, and glycinergic neurons in the auditory pathways of macaque monkeys. Neuroscience 310, 128–151, (2015).

  12. 12.

    Oishi, T. et al. Sporadic premature aging in a Japanese monkey: a primate model for progeria. PLoS One 9, e111867, (2014).

  13. 13.

    Pfluger, L. S. et al. Allelic variation of the COMT gene in a despotic primate society: A haplotype is related to cortisol excretion in Macaca fuscata. Horm Behav 78, 220–230, (2016).

  14. 14.

    Yoshida, K. et al. Single-neuron and genetic correlates of autistic behavior in macaque. Sci Adv 2, e1600558, (2016).

  15. 15.

    Suzuki, N. et al. Identification of non-taster Japanese macaques for a specific bitter taste. Primates 51, 285–289, (2010).

  16. 16.

    Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676, (2006).

  17. 17.

    Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872, (2007).

  18. 18.

    Gallego Romero, I. et al. A panel of induced pluripotent stem cells from chimpanzees: a resource for comparative functional genomics. Elife 4, e07103, (2015).

  19. 19.

    Marchetto, M. C. N. et al. Differential L1 regulation in pluripotent stem cells of humans and apes. Nature 503, 525–529, (2013).

  20. 20.

    Wunderlich, S. et al. Primate iPS cells as tools for evolutionary analyses. Stem Cell Res 12, 622–629, (2014).

  21. 21.

    Enard, W. Functional primate genomics–leveraging the medical potential. J Mol Med (Berl) 90, 471–480, (2012).

  22. 22.

    Otani, T., Marchetto, M. C., Gage, F. H., Simons, B. D. & Livesey, F. J. 2D and 3D Stem Cell Models of Primate Cortical Development Identify Species-Specific Differences in Progenitor Behavior Contributing to Brain Size. Cell Stem Cell 18, 467–480, (2016).

  23. 23.

    Prescott, S. L. et al. Enhancer divergence and cis-regulatory evolution in the human and chimp neural crest. Cell 163, 68–83, (2015).

  24. 24.

    Mora-Bermudez, F. et al. Differences and similarities between human and chimpanzee neural progenitors during cerebral cortex development. Elife 5, (2016).

  25. 25.

    Enard, W. The Molecular Basis of Human Brain Evolution. Curr Biol 26, R1109–R1117, (2016).

  26. 26.

    Imamura, M. et al. Derivation of induced pluripotent stem cells by retroviral gene transduction in mammalian species. Methods Mol Biol 925, 21–48, (2012).

  27. 27.

    Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. & Hasegawa, M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 85, 348–362, (2009).

  28. 28.

    Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 8, 409–412, (2011).

  29. 29.

    Okita, K. et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31, 458–466, (2013).

  30. 30.

    Hirai, H., Hasegawa, Y., Kawamoto, Y. & Tokita, E. Tandem duplication of nucleolus organizer region (NOR) in the Japanese macaque, Macaca fuscata fuscata. Chromosome Res 6, 191–197 (1998).

  31. 31.

    Stanyon, R., Ardito, G., Lamberti, L. & Bigatti, P. The banded karyotypes of Macaca fuscata compared with Cercocebus aterrimus. Folia Primatol (Basel) 41, 137–146, (1983).

  32. 32.

    Onuma, Y., Tateno, H., Hirabayashi, J., Ito, Y. & Asashima, M. rBC2LCN, a new probe for live cell imaging of human pluripotent stem cells. Biochem Biophys Res Commun 431, 524–529, (2013).

  33. 33.

    Kawabe, K. et al. A novel antibody for human induced pluripotent stem cells and embryonic stem cells recognizes a type of keratan sulfate lacking oversulfated structures. Glycobiology 23, 322–336, (2013).

  34. 34.

    Okada, Y. et al. Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem/progenitor cells. Stem Cells 26, 3086–3098, (2008).

  35. 35.

    Shimada, H. et al. Efficient derivation of multipotent neural stem/progenitor cells from non-human primate embryonic stem cells. PLoS One 7, e49469, (2012).

  36. 36.

    Nori, S. et al. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci USA 108, 16825–16830, (2011).

  37. 37.

    Morizane, A., Doi, D., Kikuchi, T., Nishimura, K. & Takahashi, J. Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells. J Neurosci Res 89, 117–126, (2011).

  38. 38.

    Nakagawa, M. et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep 4, 3594, (2014).

  39. 39.

    Hasegawa, K. et al. Wnt signaling orchestration with a small molecule DYRK inhibitor provides long-term xeno-free human pluripotent cell expansion. Stem Cells Transl Med 1, 18–28, (2012).

  40. 40.

    Kinehara, M. et al. Protein kinase C regulates human pluripotent stem cell self-renewal. PLoS One 8, e54122, (2013).

  41. 41.

    Strassler, E. T., Aalto-Setala, K., Kiamehr, M., Landmesser, U. & Krankel, N. Age Is Relative-Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality. Front Cardiovasc Med 5, 4, (2018).

  42. 42.

    Mahmoudi, S. & Brunet, A. Aging and reprogramming: a two-way street. Curr Opin Cell Biol 24, 744–756, (2012).

  43. 43.

    Imaizumi, Y. & Okano, H. Modeling human neurological disorders with induced pluripotent stem cells. J Neurochem 129, 388–399, (2014).

  44. 44.

    Estrada, A. et al. Impending extinction crisis of the world’s primates: Why primates matter. Sci Adv 3, e1600946, (2017).

  45. 45.

    Selvaraj, V., Wildt, D. E. & Pukazhenthi, B. S. Induced pluripotent stem cells for conserving endangered species? Nat Methods 8, 805–807, (2011).

  46. 46.

    Imamura, M., Hikabe, O., Lin, Z. Y. & Okano, H. Generation of germ cells in vitro in the era of induced pluripotent stem cells. Mol Reprod Dev 81, 2–19, (2014).

Download references


We thank Johanna Geuder, Sawako Okada, Emiko Suzuki, Yuriko Hirai, Kaori Yasutake, Haruhisa Inoue, Suga Hasegawa, Haruhiko Iwaoki, and Hiroo Imai for technical assistance and other support. This work was supported by grants from the Japan Society for the Promotion of Science (JSPS); Leave a Nest Grants (Life Technologies Japan Award, On-chip Biotechnologies Award, SCREEN Holdings Award, L-RAD Award); Interuniversity Bio-Backup Project for Basic Biology; the Brain Sciences Project of the Center for Novel Science Initiatives (CNTI), National Institutes of Natural Sciences (NINS); Aichi Cancer Research Foundation; Takeda Science Foundation; The Kyoto University Foundation; The Hori Science and Arts Foundation; and Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University. R.N. was supported by DAIKO Foundation. M.O. was supported by JSPS overseas research fellowship and Boehringer Ingelheim Fonds.

Author information

M.O., M.N., W.E., and M.I. conceived and designed the experiments. M.O., K.K., R.K. and M.N. established jm-iPSCs and R.N., K.K., H.I., H.H., R.K., T.F. and M.I. performed molecular and cellular characterization of them. R.N. and H.I. performed in vitro differentiation of jm-iPSCs. M.I. wrote the manuscript.

Competing Interests

The authors declare no competing interests.

Correspondence to Masanori Imamura.

Electronic supplementary material

Supplementary Figures

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.